[A15-42] Pomalidomide - Benefit assessment according to §35a Social Code Book V
Last updated 04.01.2016
Commission awarded on 30.09.2015 by the Federal Joint Committee (G-BA).
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
|A19-50||Pomalidomide (multiple myeloma) - Benefit assessment according to §35a Social Code Book V||Commission completed|
|A16-07||Pomalidomide - Addendum to Commission A15-42||Commission completed|
Federal Joint Committee (G-BA)
2016-03-17 A G-BA decision was published.